Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis

類似資料

• Potential Therapeutic Targets and Promising Agents for Combating NAFLD
  著者:: Atsushi Umemura, 等
  出版事項: (2022-04-01)
• FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
  著者:: Seko, Yuya, 等
  出版事項: (2019)
• Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan
  著者:: Yano, Kota, 等
  出版事項: (2020)
• The Association between the Platelet Count and Liver Volume in Compensated Cirrhosis Patients after the Eradication of Hepatitis C virus by Direct-acting Antivirals
  著者:: Seko, Yuya, 等
  出版事項: (2020)
• Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
  著者:: Seko, Yuya, 等
  出版事項: (2018)